Several studies have demonstrated that administration of different preparations of oligomeric tau (synthetic, from transgenic mice or from AD brains) impaired synaptic plasticity and memory [8, 10, 13, 16–18]. This evidence concerns the gene MAPT and Alzheimer disease.